Podrobno

Deforestacija v Peruju : zaključna seminarska naloga
ID Dačić, Uršula (Avtor), ID Ogrin, Darko (Mentor) Več o mentorju... Povezava se odpre v novem oknu

.pdfPDF - Predstavitvena datoteka, prenos (1,91 MB)
MD5: 4B6E5CD5FC018BF0ED46AE425C974BEE
PID: 20.500.12556/rul/5fe9b4f9-30de-4b66-9d10-6eaf6e9a8fd2

Jezik:Slovenski jezik
Ključne besede:zaključne seminarske naloge, geografske diplome, Peru, gozdovi, tropski gozd, varstvo gozdov, biodiverziteta
Vrsta gradiva:Diplomsko delo/naloga
Tipologija:2.11 - Diplomsko delo
Organizacija:FF - Filozofska fakulteta
Kraj izida:Ljubljana
Založnik:[U. Dačić]
Leto izida:2013
Št. strani:32 str.
PID:20.500.12556/RUL-29287 Povezava se odpre v novem oknu
UDK:502.52:630*1(213.5)(85)
COBISS.SI-ID:52667234 Povezava se odpre v novem oknu
Datum objave v RUL:19.08.2014
Število ogledov:2917
Število prenosov:1258
Metapodatki:XML DC-XML DC-RDF
:
DAČIĆ, Uršula, 2013, Deforestacija v Peruju : zaključna seminarska naloga [na spletu]. Diplomsko delo. Ljubljana : U. Dačić. [Dostopano 4 junij 2025]. Pridobljeno s: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=slv&id=29287
Kopiraj citat
Objavi na:Bookmark and Share

Podobna dela

Podobna dela v RUL:
  1. ǂThe ǂimportance of cancer stem cells and epithelial-mesenchymal transition in the progression of non-small cell lung cancer
  2. Gene expression levels of the prolyl hydroxylase domain proteins PHD1 and PHD2 but not PHD3 are decreased in primary tumours and correlate with poor prognosis of patients with surgically resected non-small-cell lung cancer
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Usefulness of immunohistochemically determined epidermal growth factor receptor mutations in lung cancer
  5. Diabetes mellitus and physical activity
Podobna dela v drugih slovenskih zbirkah:
  1. Expression patterns and prognostic relevance of subtype-specific transcription factors in surgically resected small cell lung cancer
  2. Outsourcing predictive biomarker testing in non-small cell carcinoma
  3. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  4. Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
  5. NSCLC molecular testing in Central and Eastern European countries

Nazaj